{"disease":{"id":"paraneoplastic-syndromes","name":"paraneoplastic syndromes"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05198661","title":"Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection","phase":"NA","overall_status":"RECRUITING","enrollment_count":3500,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03963700","title":"Tumor Characteristics in Patients With Paraneoplastic Neurological Syndromes (PNS)","phase":"","overall_status":"UNKNOWN","enrollment_count":980,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05942872","title":"CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term Outcomes, Predictors, and Survival.","phase":"","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07491328","title":"Liquid Biopsy in Paraneoplastic Neurological Syndromes","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Heinrich-Heine University, Duesseldorf","has_results":false},{"nct_id":"NCT04653571","title":"CASPR2 Encephalitis Initial Symptoms","phase":"","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05645185","title":"Characterisation of Clinical Phenotypes and Outcomes of Ma2 Patient","phase":"","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06915103","title":"A Case Report of NMDAR Encephalopathy","phase":"","overall_status":"COMPLETED","enrollment_count":1,"lead_sponsor_name":"Mayo Clinic","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}